2024 Latest Drug Guidelines for Osimertinib

Osimertinib is a kinase inhibitor indicated as adjuvant treatment after tumor resection in adult patients with non-small cell lung cancer whose tumors have epidermal growth factor receptors, as measured by a U.S. Food and Drug Administration (FDA) approved test (EGFR) The 19 exon is deleted or the 21exon L858Rmutation. U.S. Food and Drug Administration (FDA)-approved test finds presence of EGFRChapter in tumors of adults with metastatic non-small cell lung cancer 19exon deletion or 21exonL858R mutation can be used as first-line treatment. A U.S. Food and Drug Administration (FDA)-approved test found that adult patients with metastatic EGFR T790M mutation-positive non-small cell lung cancer progressed during or after treatment with an EGFR·TKI.

Osimertinib(Osimertinib)What is the dosage?

Adjuvant therapy for early-stage non-small cell lung cancer The recommended dose is 80 mg taken orally once daily, with or without food, until disease relapse or toxicity is unacceptable, or for up to 3 years. The recommended dose for metastatic non-small cell lung cancer is 80 mg orally once daily with or without food until disease progression or unacceptable toxicity.

Osimertinib(Osimertinib)What are the side effects?

The most common adverse reactions (including laboratory abnormalities) with osimertinib include leukopenia, lymphopenia, thrombocytopenia, diarrhea, anemia, rash, musculoskeletal pain, nail toxicity, neutropenia, dry skin, stomatitis, fatigue, and cough. Generic drugs cost several hundred yuan per box. Different versions have different prices. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.